Viewing StudyNCT05019677



Ignite Creation Date: 2024-05-06 @ 4:31 PM
Last Modification Date: 2024-10-26 @ 2:12 PM
Study NCT ID: NCT05019677
Status: WITHDRAWN
Last Update Posted: 2022-04-04
First Post: 2021-08-18

Brief Title: GP Chemotherapy in Combination With Tislelizumab and Ociperlimab as First-line Treatment in Advanced BTC
Sponsor: Fudan University
Organization: Fudan University

Key Dates - Follows AllAPIJSON File Order

Start Date: 2021-09-01
Start Date Type: ESTIMATED
Primary Completion Date: 2024-12-01
Primary Completion Date Type: ESTIMATED
Completion Date: 2024-12-01
Completion Date Type: ESTIMATED
First Submit Date: 2021-08-18
First Submit QC Date: August 18 2021
Study First Post Date: 2021-08-25
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2022-03-22
Last Update Post Date: 2022-04-04
Last Update Post Date Type: ACTUAL